ID   NCC-GCTB6-C1
AC   CVCL_C2WT
DR   Wikidata; Q123033141
RX   PubMed=37328637;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 21 hours (PubMed=37328637).
CC   Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Gly35Trp (c.103G>T) (G34W); Zygosity=Heterozygous (PubMed=37328637).
CC   Omics: Phenotyping; Drug screening.
CC   Derived from site: In situ; Bone, right distal femur; UBERON=UBERON_0004406.
ST   Source(s): PubMed=37328637
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 10
ST   D16S539: 9,10
ST   D21S11: 30,31.2
ST   D5S818: 10,13
ST   D7S820: 11,12
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C4304; Malignancy in giant cell tumor of bone
DI   ORDO; Orphanet_363976; Giant cell tumor of bone
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
RX   PubMed=37328637; DOI=10.1007/s13577-023-00928-0;
RA   Ono T., Noguchi R., Yoshimatsu Y., Sin Y., Tsuchiya R., Akiyama T.,
RA   Kojima N., Toda Y., Sato C., Fukushima S., Yoshida A., Kawai A.,
RA   Kondo T.;
RT   "Establishment and characterization of two novel patient-derived cell
RT   lines from giant cell tumor of bone.";
RL   Hum. Cell 36:1804-1812(2023).
//